Explore BrainMass

Explore BrainMass

    E12-16 Leontyne Price Company: Accounting for R&D Costs

    This content was COPIED from BrainMass.com - View the original, and get the already-completed solution here!

    E12-16 (Accounting for R&D Costs) Leontyne Price Company from time to time embarks on a research program when a special project seems to offer possibilities. In 2006 the company expends $325,000 on a research project, but by the end of 2006 it is impossible to determine whether any benefit will be derived from it.

    (a) What account should be charged for the $325,000, and how should it be shown in the financial statements?

    (b) The project is completed in 2007, and a successful patent is obtained. The R&D costs to complete the project are $110,000. The administrative and legal expenses incurred in obtaining patent number 472-1001-84 in 2007 total $16,000. The patent has an expected useful life of 5 years. Record these costs in journal entry form. Also, record patent amortization (full year) in 2007.

    (c) In 2008, the company successfully defends the patent in extended litigation at a cost of $47,200, thereby extending the patent life to December 31, 2015. What is the proper way to account for this cost? Also, record patent amortization (full year) in 2008.

    (d) Additional engineering and consulting costs incurred in 2008 required to advance the design of a product to the manufacturing stage total $60,000. These costs enhance the design of the product considerably. Discuss the proper accounting treatment for this cost.

    © BrainMass Inc. brainmass.com June 3, 2020, 9:55 pm ad1c9bdddf

    Solution Preview

    (a) The expenses of $325,000 is an R&D cost as per FASB Statement 2 and it should be charged to R&D Expense. In case, R&D cost is not separately disclosed in the income statement, the notes to financial statements should disclose the total cost of R&D.

    Journal entry for R&D Cost
    R&D Expense 110,000
    Cash ...

    Solution Summary

    This post answer some questions on how to account for R&D costs.